Cargando…
Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin
Hereditary angioedema (HAE) is characterized by recurrent localized edema in various organs, which can be potentially fatal. There are different types of hereditary angioedema, which include genetic deficiency of C1 inhibitor (C1-INH) and hereditary angioedema with normal C1-INH (HAEnCI). In HAEnCI...
Autores principales: | Hintze, Stefan, Möhl, Britta S., Beyerl, Jessica, Wulff, Karin, Wieser, Andreas, Bork, Konrad, Meinke, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849239/ https://www.ncbi.nlm.nih.gov/pubmed/36685169 http://dx.doi.org/10.3389/fphys.2022.1090732 |
Ejemplares similares
-
Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin
Receptor Antagonism
por: Riedl, Marc
Publicado: (2010) -
Bradykinin and the Pathogenesis of Hereditary Angioedema
por: Kaplan, Allen P
Publicado: (2011) -
The FXII c.-4T>C Polymorphism as a Disease Modifier in Patients With Hereditary Angioedema Due to the FXII p.Thr328Lys Variant
por: Corvillo, Fernando, et al.
Publicado: (2020) -
Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen gene
por: Bork, Konrad, et al.
Publicado: (2020) -
Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants
por: Marceau, François, et al.
Publicado: (2020)